Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I of Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131

NCT01296204 is registered in ClinicalTrials.gov with Centre René Gauducheau as lead sponsor.

NCT NCT01296204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01296204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I of Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131
Lead sponsor
Centre René Gauducheau
Phase
Phase 1
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
33
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma